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With increasing age, the ability of the human immune system to protect against new antigenic challenges or to control chronic infections declines 1, 2 . More than 90% of all influenza-related deaths in the United States occur in the elderly 3 , in whom the mortality and morbidity due to infections is high and the response to vaccinations is diminished 4, 5 .
There are many putative mechanisms that can explain age-related decrements in adaptive immunity. Declining thymic function has frequently been implicated [6] [7] [8] , but in spite of thymic demise in midadulthood, declines in naive CD4 + T cell compartment sizes with age are subtle 9 . Moreover, TCR diversity within the naive CD4 + T cell compartment in 60-to 65-year-old individuals is not significantly different from that in 20-to 30-year-old individuals and the diversity only contracts late in life 10, 11 . Thus, individuals maintain a diverse repertoire of naive CD4 + T cells, which should endow them with the competence to respond to antigenic challenges or vaccinations into their eighth decade of life.
In mice, an increasing lifespan of naive CD4 + T cells with age has been associated with the emergence of functional defects 12 . TCR signaling is substantially and globally impaired, preferentially affecting the ability of naive CD4 + T cells to produce interleukin-2 (IL-2). Human CD4 + naive T cells are also affected by age; in particular, homeostatic proliferation results in a substantial cumulative telomeric loss that impairs proliferative responses 13, 14 .
In contrast to the situation in mice, global age-dependent changes in human TCR signaling can generally be attributed to expanded effector cell populations that have lost the co-stimulatory CD27 and CD28 molecules and gained numerous inhibitory cell surface molecules 15 . Major signaling defects, such as the lack of calcium influx observed in mouse naive CD4 + T cells, are not seen in humans, and any signaling alterations that occur are subtle and dependent on signal strength 16 .
Over the last decade, signal threshold calibration after TCR stimulation has been increasingly defined, and many settings have been identified where signal strength determines remarkably different functional outcomes, ranging from positive and negative selection in thymic development to recognition of agonistic and antagonistic peptides in peripheral T cells and differentiation into effector cell lineages 17 . Among the molecular components calibrating TCR-induced signal strength, feedback loops involving ERK activity are crucial 18 . TCR threshold calibration is most evident in the differentiation from thymocytes to mature T cells. Recognition of self peptides is instrumental for thymocyte development; whereas the repertoire is purged from cells recognizing self with high affinity, differentiation into mature T cells requires positive selection induced by the recognition of lower-affinity self peptides. Recognition of these peptides by mature T cells does not trigger a productive T cell response. This difference in responsiveness has in part been attributed to a recalibration of TCR signaling thresholds. In support of this notion, expression of several phosphatases including DUSP5 and DUSP6 increases with the transition from thymocyte to T cell 19, 20 . DUSPs represent a family of phosphatases that dephosphorylate phosphothreonine and phosphotyrosine residues on mitogen-activated protein kinase (MAPK) and that are pivotal regulators of MAPK activities 21, 22 .
Here we report that naive CD4 + T cells from elderly individuals have a reduced signaling capacity of the ERK pathway. The underlying mechanism is an age-related decline in miR-181a expression and associated rise in levels of DUSP6 expression. The higher levels of DUSP6 raise the threshold for productive T cell activation by dampening the initial ERK signal after TCR stimulation. Accordingly, lower fractions of naive CD4 + T cells are activated in the elderly, in particular in response to low-affinity stimuli. Our studies suggest that DUSP6 inhibition may be a potential intervention to improve T cell responses in the elderly.
RESULTS

Decreased sensitivity to TCR stimulation with age
The frequency of naive CD4 + T cells changes with age, but this decline does not fully explain the defective T cell response observed in the elderly, suggesting T cell-intrinsic defects. We probed T cell function under relatively physiological conditions by stimulating purified naive CD4 + T cells from healthy individuals of different age groups with the superantigen toxic shock syndrome toxin-1 (TSST-1) presented by myeloid dendritic cells (mDCs) from young adults ( Supplementary Fig. 1 ). TSST-1 is known to stimulate all Vβ2 + and a small fraction of Vβ2 − T cells, the latter only at higher concentrations, which suggests that these cells have a lower affinity for TSST-1. We adjusted the number of DCs in the system so that an alloreactive response in the absence of TSST-1 was not detectable. In initial kinetic experiments, we determined the fraction of Vβ2 + naive CD4 + T cells that were stimulated to express CD69 and CD25. Expression of these activation markers in elderly naive CD4 + T cells was delayed, suggesting that longer stimulation is needed for elderly T cells to build up the required signaling strength ( Fig. 1a) .
To examine this possibility in more detail, we determined the fraction of naive CD4 + T cells that were activated in 11 20-to 35-year-old and 11 70-to 85-year-old individuals in response to decreasing doses of TSST-1 ( Fig. 1b) . At high doses, approximately 90% of Vβ2 + T cells proliferated independent of age. With decreasing doses, a difference became apparent. Dose-response curves were shifted for the elderly toward higher doses of antigen by a factor of approximately 10. In subsequent experiments with naive CD4 + T cells from 35 20-35 and 17 70-to 85-year-old individuals at a low TSST-1 concentration of 0.04 ng ml −1 , a significantly lower number of naive CD4 + T cells responded to stimulation in the elderly individuals (Fig. 1c) . The difference was more pronounced for Vβ2 − naive CD4 + T cells (P < 0.0001) than for Vβ2 + cells (P = 0.002). npg Taken together, these data suggest that TCR activation thresholds are increased in naive CD4 + T cells from elderly individuals and that productive activation requires higher antigen doses or higher affinity antigens.
Age-associated TCR defects and overexpression of DUSP6
To probe early signaling events after TCR stimulation, we used phosphoepitope analysis by flow cytometry. CD3 cross-linking induced equal phosphorylation of ZAP70 when we compared naive and memory CD4 + T cells from 15 20-to 35-year-old and 15 70-to 85-year-old adults, suggesting that initial signaling is intact and not affected by age ( Fig. 1d) . Also, phospholipase C-γ1 (PLC-γ1) phosphorylation, which is just upstream of inositol trisphosphate generation and calcium flux was not age dependent ( Fig. 1d) , indicating that human T cells do not show the signature of defective calcium signaling that is characteristic for immune aging in mice 23 . In contrast, naive CD4 + T cells from young adults were significantly more effective in phosphorylating ERK; results from 20 young and 20 elderly individuals are shown in Figure 1d (P < 0.0001). We did not observe a similar difference in ERK phosphorylation for memory CD4 + T cells. Studies examining phorbol myristate acetate (PMA)-induced ERK phosphorylation indicated that the defect affects the ERK pathway distal to Ras and Raf activation. ERK phosphorylation due to PMA-induced phosphoinositide 3-kinase activation was significantly different between the two age groups (P < 0.05, Fig. 1e ).
One major feedback loop that controls the activation of the ERK pathway in T cells and that attenuates TCR signaling involves DUSP6, a cytoplasmic phosphatase with substrate specificity for phosphorylated ERK. Increased Dusp6 protein expression during T cell development has been implicated in the reduced sensitivity of mature mouse T cells to respond to self-antigens compared to thymocytes 19 . Given the selective decrease in TCR-induced ERK activation, we explored whether human expression of DUSP6 increases with aging. DUSP6 was more abundant in CD4 + T cells from 70-to 85-yearold adults compared to young adults, as determined by western blot analysis ( Fig. 2a , P = 0.01). This increase was entirely due to the naive CD4 + population (P = 0.008), as we did not see a difference for memory CD4 + T cells ( Fig. 2b) . To determine the relationship between age and DUSP6 expression in more detail, we examined naive and memory CD4 + T cells from 60 additional individuals with similar numbers of individuals for each age decade between 20 and 80 years. DUSP6 protein expression in naive CD4 + T cells linearly increased throughout the entire age range (r = 0.68, P < 0.0001), whereas it did not show a significant age dependency in CD4 + memory T cells (r = 0.25, not significant ( Fig. 2c and Supplementary Fig. 2) ).
Loss in miR-181a accounts for increased DUSP6 expression
Increased DUSP6 protein expression with age was not reflected at the transcript level. DUSP6 transcript numbers in total CD4 + T cells from 20 20-to 35- year-old and 20 70-to 85-year-old individuals were similar, as determined by quantitative PCR (qPCR) (Fig. 3a) . Memory CD4 + T cells tended to have lower transcript levels than naive CD4 + T cells, both in the young and the old (Fig. 3a) . In a previous study in mice, Dusp6 was one of several phosphatases controlled by miR-181a 19 . We therefore determined whether expression of miR-181a in CD4 + T cells changes with age. Comparison of CD4 + T cells from 21 20-to 35-yearold and 21 70-to 85-year-old individuals showed a threefold decline in miR-181a expression ( Fig. 3b , P = 0.0005), which was mostly attributable to the naive population ( Fig. 3c , P = 0.0008). Memory CD4 + T cells had lower miR-181a expression than naive CD4 + T cells in the young (P = 0.004) and showed only a small further decrease with age. In contrast, miR-142 expression, examined as a system control, did not change with age (Fig. 3b) . The decline in miR-181a expression in naive CD4 + T cells was progressive throughout adult life. miR-181a expression was assessed in a cohort of 58 individuals, in part overlapping with those studied in Figure 3c . Levels declined in naive T cells with age ( Fig. 3d , r = −0.59, P < 0.0001), but only insignificantly in memory CD4 + T cells ( Fig. 3d , r = −0.19, P = 0.36).
Comparison of miR-181a expression and DUSP6 protein expression yielded a significant negative correlation ( Fig. 4a , r = −0.51, P < 0.0001), which could reflect our finding that both parameters correlate with age. To explore whether there may be a causal relationship between DUSP6 and miR-181a expression as described for the mouse system 19 , we determined partial correlations between miR-181a and DUSP6 after adjustments for age. An inverse relationship was found in young (23-37 years) and middle-aged (37-55 years) adults, consistent with the notion that miR-181a regulates DUSP6 expression. We did not find a correlation for individuals older than 55 years, possibly indicating that miR-181a levels were too low to influence DUSP6 expression ( Fig. 4b and Supplementary Fig. 3 ). To confirm whether the decrease in miR-181a is responsible for increased DUSP6 expression, we transfected CD4 + T cells from elderly individuals with miR-181a precursor and determined DUSP6 protein expression by western blot analysis. A representative experiment shows a reduced npg DUSP6 band intensity in CD4 + T cells that were transfected with miR-181a precursor (Fig. 4c) . Notably, elderly CD4 + T cells transfected with the miR-181a had higher expression of activation markers after CD3 stimulation compared to control-transfected T cells. Increased IL-2 production achieved by restoring miR-181a levels was reversed by parallel forced overexpression of DUSP6 ( Fig. 4d) . Activation-induced expression of CD69 was enhanced by either increasing miR-181a or silencing DUSP6 expression. Double transfection with DUSP6targeting siRNA and miR-181a precursor facilitated only a small additional increase in CD69 expression ( Fig. 4e) . Conversely, miR-181a silencing reduced activation-induced CD69 expression compared to control-transfected cells (Fig. 4f) . Co-transfection with DUSP6targeting siRNA reversed the effect of transfection with miR-181a inhibitor alone. In summary, these experiments are consistent with the interpretation that miR-181a regulates the human TCR threshold by controlling DUSP6 expression. The minor synergistic action between DUSP6 silencing and miR-181a overexpression is probably due to incomplete silencing in the singly transfected cells. Furthermore, expression levels of protein tyrosine phosphatase, non-receptor type 22 (PTPN22) and SH2 domain-containing phosphatase (SHP-2), which are also targeted by miR-181a in mice, were not influenced by age in human T cells (Fig. 4g) . However, the effect of miR-181a on DUSP5, which is also regulated by miR-181a in mice, was undetermined because the expression levels in human T cells were too low to be detected with the available antibody (data not shown).
Increased miR-181a expression restores elderly T cell responses
To determine whether restoration of miR-181a levels improves T cell activation in the elderly, we transfected T cells from 11 20-to 35-year-old and 11 70-to 85-year-old individuals with miR-181a precursor or miRNA precursor negative control. We determined ERK phosphorylation after cross-linking with antibody to CD3 in gated naive and memory CD4 + T cells by PhosphoFlow (Fig. 5a) . Consistent with the data shown in Figure 1 , activation-induced ERK phosphorylation was reduced in elderly naive but not memory CD4 + T cells.
Overexpression of miR-181a improved the ERK response significantly in elderly naive CD4 + T cells (P = 0.002) to approximately the same response level seen in young adults. We observed a smaller increase in naive CD4 + T cells from young adults, but it still reached significance (P = 0.03). In contrast, the ERK response in CD4 + memory T cells was not influenced by miR-181a overexpression in young adults and only slightly improved in the elderly. Increased ERK responses were relevant for T cell function. Upon TCR stimulation, T cells from elderly individuals expressed increased transcript numbers of MYC (encoding c-Myc; P = 0.008) and CCND1 (encoding cyclin D1; P = 0.01) when transfected with miR-181a compared to control-transfected cells (Fig. 5b) . In parallel, activation-induced expression of IL-2 (P = 0.02) and CD25 (P = 0.004) in naive CD4 + T cells increased (Fig. 5c) . Also, miR-181a overexpression augmented proliferative responses to CD3 cross-linking ( Fig. 5d) and stimulation with DCs and TSST-1 (Fig. 5e) . 
DUSP6 inhibition augments T cell activation
Given that increased expression of DUSP6 is the major consequence of miR-181a loss in elderly human CD4 + T cells, we reasoned that inhibition of DUSP6 may be sufficient to restore CD4 + T cell activation. When we transfected CD4 + T cells with DUSP6-targeting siRNA, a decline in protein expression was evident after 48 h ( Fig. 6a and Supplementary Fig. 4) ; we saw similar results with two different siRNA sequences. Transfected CD4 + T cells from 60-to 80-year-old individuals were maintained for 48 h and then stimulated with suboptimal concentrations of antibodies to CD3 and CD28. Silencing of DUSP6 increased induction of CD69 (P < 0.0001), CD25 (P < 0.0001) and IL-2 (P < 0.0001) ( Fig. 6b) . Increased IL-2 production by silencing of endogenous DUSP6 was overcome by forced overexpression of DUSP6 (Fig. 6c ). DUSP6 silencing also increased proliferative responses, in particular at low concentrations of stimulating CD3specific monoclonal antibody ( Fig. 6d) or in response to stimulation with TSST-1 and DCs (Fig. 6e) . We found similar results with the second DUSP6-targeting siRNA (Supplementary Fig. 5 ). With optimal doses of CD3-specific monoclonal antibody, proliferative responses in DUSP6-silenced and control T cells reached the same plateau, which is consistent with the interpretation in Figure 1 that low-affinity antigen responses were more affected in the elderly. Initial TCR signal strength not only determines whether a T cell is activated but also has lasting effects on T cell differentiation. High signal strength favors a T helper type 1 (T H 1) response, and low signal strength a T H 2 response. To determine whether DUSP6 activity influences T cell polarization, we activated naive CD4 + T cells transfected with DUSP6-targeting siRNA and cultured them under T H 1-and T H 2-polarizing conditions. DUSP6 silencing supported the induction of a T H 1 response (P = 0.003) while disfavoring differentiation into T H 2 cells (P = 0.0006) compared to T cells transfected with control siRNA (Fig. 6f) .
These results support the notion that DUSP6 is a suitable pharmacological target for improving naive CD4 + T cell responses, particularly in the elderly. (E)-2-benzylidene-3-(cyclohexylamino)-2,3-dihydro-1H-inden-1-one (BCI) has been shown to be an inhibitor of DUSP6 activity 24 . As BCI binds an allosteric site and not the catalytic phosphatase domain, its cross-reactivity is limited. We stimulated peripheral blood mononuclear cells (PBMCs) from ten 60-to 85-year-old individuals under suboptimal conditions with antibodies to CD3 and CD28 in the presence of increasing concentrations of BCI. We quantified the mean fluorescent intensity (MFI) of CD69 and CD25 as markers of T cell activation. BCI enhanced induction of CD69 expression on naive T cells (P < 0.0001) (Fig. 6g) in a dosedependent manner. BCI treatment also enhanced CD25 expression and IL-2 production in naive CD4 + T cells (Fig. 6g) .
DISCUSSION
Our studies demonstrate that naive CD4 + T cells lose TCR sensitivity and signaling strength with age as a result of reduced expression of miR-181a. As miR-181a represses DUSP6, DUSP6 protein concentrations increase with age, dampening ERK activation. ERK activity is a pivotal regulator of TCR threshold calibration, as it controls positive feedback loops in the TCR-induced activation cascade; reduced ERK activity impairs signal strength and activation of individual T cells. Moreover, owing to an increased TCR threshold setting, only T cells with higher affinity to antigen are activated, leading to a contracted immune response to a given antigenic peptide. Thus, inhibition of DUSP6 could be a key intervention to strengthen and broaden naive CD4 + T cell responses in the elderly.
Declining regenerative capacity and an inability to maintain a balance between functional T cell subsets and a diverse TCR repertoire have been held responsible for the deteriorating adaptive immune response with age 11, 25, 26 . Indeed, homeostasis of CD8 + T cells is not well maintained with age, naive and central memory CD8 + T cells are lost while terminally differentiated effector T cells accumulate with age, and clonal CD8 + T cell expansions dominate the repertoire of the elderly 9, 27 . CD8 + T cell oligoclonality and senescence npg correlate with poor vaccine responses and general mortality and may account for the prolonged viremia in elderly patients infected with influenza [28] [29] [30] . In contrast, CD4 + T cell homeostasis is better maintained over a lifetime 31 . In spite of thymic demise in mid-adulthood, the compartment sizes of naive and central memory CD4 + T cells are substantial, and expansion of the CD28 − CD4 + T cell population is infrequent and usually related to disease 15 . Nevertheless, adaptive immune responses that rely on CD4 + T cell function, such as the production of antibodies after vaccination, are impaired with age 4 . Whereas signaling studies in mouse systems have been very successful in defining age-related defects 32 , including a defect in the ERK pathway 33 , initial findings with human T cells 34, 35 have not been further studied and defects are not well characterized, in part because human age-related defects are more variable and subtle and are difficult to quantify, given the changes in T cell subset distributions with age. Also, transcription of signaling molecules involved in TCR signaling does not appear to be influenced by age 36 . In the present study we demonstrate a selective dampening of the ERK signaling pathway. This defect was seen in naive CD4 + T cells and did not involve naive or memory CD8 + T cells (G.L., C.M.W. and J.J.G., unpublished observation) or memory CD4 + T cells. The underlying mechanism is a loss in miR-181a and, therefore, is not obvious in transcriptional studies.
The concept that the expression level of an miRNA acts as a rheostat that controls TCR signaling and accounts for different TCR sensitivities at different developmental stages has been introduced previously 19 . Immature T cell precursor populations such as CD4 + CD8 + doublepositive thymocytes undergoing selection through the recognition of self-antigen express high levels of miR-181a. Inhibition of this miRNA impairs positive and negative selection. In contrast, mature T H 1 and T H 2 cells express low levels of miR-181a, decreasing TCR sensitivity. Overexpressing miR-181a increased signaling strength and facilitated responses to partially agonistic or antagonistic peptides 19 . In consensus with these mouse studies, we found a higher expression of miR-181a in naive CD4 + T cells compared to memory CD4 + T cells in young adults. Naive CD4 + T cells from elderly individuals have similar miR-181a expression levels as young memory T cells. However, they do not have any other phenotypic features of memory T cells, suggesting that they are not memory T cells masquerading as naive. It is possible that cumulative homeostatic proliferation over a lifetime generates a similar loss of miR-181a as memory cell differentiation 37 .
In mice, miR-181a modulated TCR sensitivity by inhibiting the protein expression of several phosphatases including Dusp5, Dusp6, SHP-2 and PTPN22 (ref. 19) . In human CD4 + T cells, we found an upregulation of DUSP6 only with age. Consistent with this finding, forced overexpression of DUSP6 in elderly T cells reversed the improved T cell responsiveness obtained from increasing miR-181a expression. The relative selectivity in humans for this one phosphatase involved in TCR threshold calibration suggests that DUSP6 inhibition may improve the npg immune response in the elderly. A small-molecule DUSP6 inhibitor has recently been described 24 , and our experiments indeed show that this inhibitor improves responses of elderly CD4 + T cells in vitro (Fig. 6g) .
The increased susceptibility of the elderly to infection represents a major public health problem. Preventive measures through vaccination are crucial; however, so far they have had only a moderate impact in preventing morbidity from infectious diseases because of reduced immune responsiveness among the elderly 38 . Improving vaccine responses to overcome age-related immune defects is a challenge but also represents a unique opportunity to attain healthy aging. Approaches have mainly targeted antigen presentation by increasing antigen dose or by using adjuvant. Influenza vaccination using an oilin-water emulsion adjuvant, MF59, has yielded increased induction of protective antibodies in all age groups, including the elderly [39] [40] [41] . Increasing the dosage of influenza and varicella zoster vaccines 42, 43 has improved clinical efficacy, consistent with the interpretation that elderly T cells have an increased threshold to respond that can be overcome by increased antigen doses. Our studies suggest that, in addition to vaccine preparation, vaccination strategies in the elderly may have to include direct targeting of the T cells by lowering the TCR activation threshold and modifying early TCR signaling.
METhODS
Methods and any associated references are available in the online version of the paper.
